MedTrace Logo

Emdogain Implementation With Transcrestal Sinus Lifting and Dental Implant Placement

NCT05507047 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 24

Last updated 2022-08-18

No results posted yet for this study

Summary

The aim of this study is to evaluate the clinical and radiographic results of implants placed using osteotome sinus floor elevation (OSFE) with and without simultaneous enamel matrix derivative (EMD) application.

Conditions

  • Osseointegration Failure of Dental Implant
  • Bone Density Increased

Interventions

DRUG

Enamel Matrix Protein

Enamel matrix derivated is used with transcrestal sinus lifting treatment

Sponsors & Collaborators

  • T.C. Dumlupınar Üniversitesi

    lead OTHER

Principal Investigators

  • Deniz Ozbay, DDS PhD · Gazi University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
99 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2017-01-31
Primary Completion
2020-01-31
Completion
2020-12-31

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05507047 on ClinicalTrials.gov